2005
DOI: 10.1016/j.biopsych.2005.02.026
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Brain Mu-Opioid Receptors in Abstinent Cocaine Users: Time Course and Relation to Cocaine Craving

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
116
0
7

Year Published

2006
2006
2016
2016

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 153 publications
(131 citation statements)
references
References 54 publications
8
116
0
7
Order By: Relevance
“…In fact, we have reported that rats maintained on high-dose methadone maintenance show no cocaine-place preference and no cocaine-induced up-regulation of mu-opioid receptor mRNA in the nucleus accumbens core (Leri et al, 2006). This is notable because the effect of cocaine exposure on mu-opioid receptor density and function in mesocorticolimbic areas (Azaryan et al, 1996;Unterwald et al, 1992;Unterwald, 2001;Yuferov et al, 1999) has been associated to the intensity of cocaine cravings in humans (Gorelick et al, 2005;Zubieta et al, 1996), and to a variety of behavioral, electrophysiological and neurochemical responses to cocaine in animals (Mathon et al, 2005a(Mathon et al, , b, 2006Tang et al, 2005;Hummel et al, 2006).…”
Section: Discussionmentioning
confidence: 95%
“…In fact, we have reported that rats maintained on high-dose methadone maintenance show no cocaine-place preference and no cocaine-induced up-regulation of mu-opioid receptor mRNA in the nucleus accumbens core (Leri et al, 2006). This is notable because the effect of cocaine exposure on mu-opioid receptor density and function in mesocorticolimbic areas (Azaryan et al, 1996;Unterwald et al, 1992;Unterwald, 2001;Yuferov et al, 1999) has been associated to the intensity of cocaine cravings in humans (Gorelick et al, 2005;Zubieta et al, 1996), and to a variety of behavioral, electrophysiological and neurochemical responses to cocaine in animals (Mathon et al, 2005a(Mathon et al, , b, 2006Tang et al, 2005;Hummel et al, 2006).…”
Section: Discussionmentioning
confidence: 95%
“…Acute oral amphetamine administration has been shown to induce endogenous opioid release in many brain regions frequently implicated in addiction, including the basal ganglia, frontal cortex areas, thalamus, and striatum (Colasanti et al, 2012;Mick et al, 2014). Further, elevated frontal/temporal cortical μ-opioid receptor binding has been observed in cocaine dependence, the degree of which was shown to positively correlate with self-reported cocaine craving (Gorelick et al, 2005), and relate to relapse following treatment (Ghitza et al, 2010;Gorelick et al, 2008). NTX has been shown to block ethanol-induced β-endorphin and subsequent dopamine release in the nucleus accumbens and provide a blockade of ethanol-induced β-endorphin inhibition of GABAergic inhibitory interneurons in the ventral tegmental area (Johnson, 2008;Zalewska-Kaszubska et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…A key modulator of the dopaminergic system is the mu opioid receptor (MOR), and opiate receptor antagonists have some efficacy in treating GD. Higher MOR availability has been reported in studies by using [ 11 C]carfentanil or [ 11 C]diprenorphine PET in cocaine, opiate and alcohol addiction (Gorelick et al 2005; Heinz et al 2005; Williams et al 2007; Williams et al 2009). However, we recently reported no difference in [ 11 C]carfentanil binding in individuals with GD (Mick et al 2015).…”
Section: Introductionmentioning
confidence: 86%